Hasil Pencarian - Butuo Li

  • Menampilkan 1 - 14 hasil dari 14
Perbaiki Hasil
  1. 1
    Multiple Immune Features-Based Signature for Predicting Recurrence and Survival of Inoperable LA-NSCLC Patients

    Multiple Immune Features-Based Signature for Predicting Recurrence and Survival of Inoperable LA-NSCLC Patients oleh Meiying Guo, Wanlong Li, Butuo Li, Butuo Li, Bing Zou, Shijiang Wang, Bingjie Fan, Xindong Sun, Linlin Wang

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Does ALK-rearrangement predict favorable response to the therapy of bevacizumab plus pemetrexed in advanced non-small-cell lung cancer? Case report and literature review

    Does ALK-rearrangement predict favorable response to the therapy of bevacizumab plus pemetrexed in advanced non-small-cell lung cancer? Case report and literature review oleh Zhichao Liu, Youting Bao, Butuo Li, Xindong Sun, Linlin Wang

    Diterbitkan 2018-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    East Asian patients who received immunotherapy‐based therapy associated with improved survival benefit in advanced non‐small cell lung cancer: An updated meta‐analysis

    East Asian patients who received immunotherapy‐based therapy associated with improved survival benefit in advanced non‐small cell lung cancer: An updated meta‐analysis oleh Yueyuan Yao, Butuo Li, Yiyue Xu, Linlin Yang, Bing Zou, Linlin Wang

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis

    Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched mul... oleh Yueyuan Yao, Butuo Li, Ruiting Song, Linlin Yang, Bing Zou, Linlin Wang

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non‐small cell lung cancer

    Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non‐small cell lung cancer oleh Qian Zhao, Butuo Li, Yiyue Xu, Shijiang Wang, Bing Zou, Jinming Yu, Linlin Wang

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Clinical multi-dimensional prognostic nomogram for predicting the efficacy of immunotherapy in NSCLC

    Clinical multi-dimensional prognostic nomogram for predicting the efficacy of immunotherapy in NSCLC oleh Qian Zhao, Xiao Zhong, Xiaoqing Wang, Butuo Li, Yiyue Xu, Jinming Yu, Linlin Wang

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Genome-wide DNA methylation signature predict clinical benefit of bevacizumab in non-small cell lung cancer

    Genome-wide DNA methylation signature predict clinical benefit of bevacizumab in non-small cell lung cancer oleh Butuo Li, Chao Jiang, Yiyue Xu, Xinyu Fan, Linlin Yang, Bing Zou, Bingjie Fan, Linlin Wang

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Delineating the pattern of treatment for elderly locally advanced NSCLC and predicting outcomes by a validated model: A SEER based analysis

    Delineating the pattern of treatment for elderly locally advanced NSCLC and predicting outcomes by a validated model: A SEER based analysis oleh Meiying Guo, Butuo Li, Yishan Yu, Shijiang Wang, Yiyue Xu, Xindong Sun, Linlin Wang, Jinming Yu

    Diterbitkan 2019-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Association between immune-related adverse events and the efficacy of PD-1 inhibitors in advanced esophageal cancer

    Association between immune-related adverse events and the efficacy of PD-1 inhibitors in advanced esophageal cancer oleh Wenru Qin, Linlin Yang, Bingjie Fan, Bing Zou, Yanan Duan, Yanan Duan, Butuo Li, Linlin Wang

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Toxicity Profile of Combining PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Systematic Review

    Toxicity Profile of Combining PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Systematic Review oleh Butuo Li, Chao Jiang, Linlin Pang, Bing Zou, Mingjun Ding, Mingjun Ding, Xindong Sun, Jinming Yu, Linlin Wang

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Comparison of proton therapy and photon therapy for early-stage non-small cell lung cancer: a meta-analysis

    Comparison of proton therapy and photon therapy for early-stage non-small cell lung cancer: a meta-analysis oleh Junyi He, Yingxin Liu, Xiaojing Zhang, Butuo Li, Linlin Yang, Haohua Wang, Shijiang Wang, Jinming Yu, Linlin Wang

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Integrated multi-dimensional deep neural network model improves prognosis prediction of advanced NSCLC patients receiving bevacizumab

    Integrated multi-dimensional deep neural network model improves prognosis prediction of advanced NSCLC patients receiving bevacizumab oleh Butuo Li, Linlin Yang, Chao Jiang, Chao Jiang, Yueyuan Yao, Haoqian Li, Shuping Cheng, Bing Zou, Bingjie Fan, Linlin Wang

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer

    From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer oleh Butuo Li, Wenru Qin, Linlin Yang, Haoqian Li, Chao Jiang, Yueyuan Yao, Shuping Cheng, Bing Zou, Bingjie Fan, Taotao Dong, Linlin Wang

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small–cell lung cancer (ES-SCLC): a phase II trialResearch in context

    Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small–cell lung cancer (ES-SCLC): a phase II trialResearch in context oleh Dawei Chen, Bing Zou, Butuo Li, Aiqin Gao, Wei Huang, Qian Shao, Xiangjiao Meng, Pinliang Zhang, Xiaoyong Tang, Xudong Hu, Yan Zhang, Jun Guo, Changhong Zhao, Jiajia Yuan, Qian Li, Changbin Zhu, Jinming Yu, Linlin Wang

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: